RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      시뮬레이션 디자인을 적용한 플로로글루시놀 설하정과 니트로글리세린 설하정의 개봉 후 안정성 평가 = In-use Stability Study of Phloroglucinol and Nitroglycerin Sublingual Tablets Using Simulation Design after Opening of their Containers

      한글로보기

      https://www.riss.kr/link?id=A104668653

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Expiration date of pharmaceuticals is established based on stability studies on the products. However it does notguarantee stability of pharmaceuticals once their containers are open. In particular pharmaceuticals stored in multi-dose containeror the ...

      Expiration date of pharmaceuticals is established based on stability studies on the products. However it does notguarantee stability of pharmaceuticals once their containers are open. In particular pharmaceuticals stored in multi-dose containeror the ones which require protection from moisture (e.g. sublingual tablets, effervescent tablets and dispersible tablets)need information on in-use stability after opening of their containers to maintain their safety, efficacy, and quality. It helps consumersto take pharmaceuticals safely. In order to study in-use stability of pharmaceuticals after opening of their containers,Phloroglucinol sublingual tablets and Nitroglycerin sublingual tablets which are sensitive to moisture or humidity wereselected. Test methods were developed referring to the applicable EMA guideline, including withdrawal method to consideractual use of pharmaceuticals. The appearance, disintegration and potency of the Phloroglucinol sublingual tablets were evaluatedat 1, 3 and 6 month after opening of containers. During 6 months, no difference in appearance and disintegration wasfound in different 3 lots. However, the potency of active ingredient was decreased gradually during 6 months and the resultsof 3 lots were 93.4%, 94.1% and 94.2%, respectively, which were out of in-house specification range (95.0~105.0%) of testproduct. In-use stability of Nitroglycerin sublingual tablets was also evaluated on appearance, disintegration, impurity andpotency at 0.5, 1, 2, 3 and 6 month after opening of containers. During 6 months, no significant difference in appearance, disintegrationand impurity were found in different 3 lots. However, the potency of active ingredient was decreased graduallyduring 6 months and the results of 3 lots was 82.1%, 83.2% and 84.1%, respectively, even though they were remained withinthe KP specification range (80.0~120.0%) of test product. Study results suggest product quality of sublingual tablets can beaffected by opening of their containers. For safe and effective use of pharmaceuticals, we recommend the Phloroglucinol sublingualtablets and Nitroglycerin sublingual tablets be stored under the minimized moisture effect and used within 6 monthsafter opening of their containers

      더보기

      참고문헌 (Reference)

      1 U.S. Pharmacopoeia National Formulary, "USP Monographs: Nitroglycerin Subligual Tablets" U.S. Pharmacopoeial Convention 2017

      2 U.S. Pharmacopoeia National Formulary, "USP General Chapters: <795> Pharmaceutical Compounding-Nonsterile Preparations" U.S. Pharmacopoeial Convention 2017

      3 "The Korean Pharmacopoeia eleven edition (2017-63)"

      4 EMA, "Note for guidance on in-use stability testing of human medicinal products" 2001

      5 National Institute of Food and Drug Safety Evaluation, "Guidance for in-use stability testing of pharmaceuticals after opening of their conatiners" 2016

      6 Yongsheng Y, "Comparative stability of repackaged metoprolol tartrate tablets" 385 : 92-, 2010

      1 U.S. Pharmacopoeia National Formulary, "USP Monographs: Nitroglycerin Subligual Tablets" U.S. Pharmacopoeial Convention 2017

      2 U.S. Pharmacopoeia National Formulary, "USP General Chapters: <795> Pharmaceutical Compounding-Nonsterile Preparations" U.S. Pharmacopoeial Convention 2017

      3 "The Korean Pharmacopoeia eleven edition (2017-63)"

      4 EMA, "Note for guidance on in-use stability testing of human medicinal products" 2001

      5 National Institute of Food and Drug Safety Evaluation, "Guidance for in-use stability testing of pharmaceuticals after opening of their conatiners" 2016

      6 Yongsheng Y, "Comparative stability of repackaged metoprolol tartrate tablets" 385 : 92-, 2010

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.2 0.2 0.22
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.18 0.403 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼